Shuang G. Zhao

University of Wisconsin Carbone Cancer Center — United States

Medicine · Health Sciences

51h-index11.2kcitations410works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(186), Cancer, Lipids, and Metabolism(54), Cancer Genomics and Diagnostics(49), Prostate Cancer Diagnosis and Treatment(44), Radiomics and Machine Learning in Medical Imaging(30)

Publications410 total

Abstract B071: Monitoring the evolution of treatment resistance by transcriptional profiling of circulating tumor cells with RNAseq
Cancer Research·2026
A Case Analysis of Antihypertensive Treatment in a Patient Undergoing CRRT with Comorbid Coronary Heart Disease
Journal of social science and cultural development.·2026Open Access
R-loops and small RNA regulatory interactions: mechanisms and clinical perspectives
Frontiers in Cell and Developmental Biology·2025Open Access
Figure S1 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Figure S4 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Supplementary Figure S1 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Supplementary Tables S1-S4 from Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer
2025Open Access
Figure S3 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Figure S2 from Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
2025Open Access
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels
Nature Communications·2025· 2 citedOpen Access
Luminal Subtypes in Metastatic Prostate Cancer Circulating Tumor Cells Mirror Tissue and Are Associated with Prognosis and Response to 177Lu-PSMA-617
International Journal of Radiation Oncology*Biology*Physics·2025
The characterization of variable new antigen receptors targeting FAP isolated from a novel immunized library
Communications Biology·2025· 1 citedOpen Access
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer
2025· 1 citedOpen Access
Hierarchical spatial attention Mamba network for predicting pathological complete response to neoadjuvant chemotherapy from breast DCE-MRI
2025
Transcriptomic Signatures of Monocyte‐Derived Macrophages Associate With Androgen Receptor Pathway Inhibitor Progression in Prostate Cancer
The Prostate·2025· 1 citedOpen Access
Author response for "Lossless Altered Histone Modification Analysis System (LAHMAS)"
2025
Author response for "Lossless Altered Histone Modification Analysis System (LAHMAS)"
2025
OGDHL regulates tumor growth, neuroendocrine marker expression, and nucleotide abundance in prostate cancer
2025Open Access
Integrated analysis of tissue genomic sequencing and high purity circulating tumor cell RNA sequencing for prostate cancer lineage states as a prognostic factor for survival and resistance to 177Lu-PSMA-617 in patients with metastatic castrate resistant prostate cancer.
Journal of Clinical Oncology·2025
Precision diagnostics in prostate cancer treatment (PREDICT): A phase 2 multi-arm biomarker based study (Alliance A032102).
Journal of Clinical Oncology·2025
page 1 of 21Next →

Frequent Co-authors

Felix Y. Feng(41), Elai Davicioni(18), Daniel E. Spratt(16), Robert B. Den(14), R. Jeffrey Karnes(13), Paul L. Nguyen(12), Ashley E. Ross(10), Edward M. Schaeffer(10), Adam P. Dicker(10), Scott A. Tomlins(9), Mohammed Alshalalfa(9), Nicholas Erho(9), Corey Speers(9), David A. Quigley(8), Christopher A. Maher(8), Eric J. Small(8), Eric A. Klein(8), Joshi J. Alumkal(7), Vishal Kothari(7), Rajdeep Das(7)